These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24906654)

  • 1. Overexpression of Nedd9 is a prognostic marker of human gastric cancer.
    Zhang Q; Wang H; Ma Y; Zhang J; He X; Ma J; Zhao ZS
    Med Oncol; 2014 Jul; 31(7):33. PubMed ID: 24906654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
    Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
    Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEDD9 overexpression correlates with poor prognosis in gastric cancer.
    Liu Y; Wang D; Zhao KL; Zhu JW; Yin HB; Wei YZ; Wu ZJ; Cheng GJ; Wang F; Ni F; Wang XL; Cao GX; Huang J; Cai J
    Tumour Biol; 2014 Jul; 35(7):6351-6. PubMed ID: 24664584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
    Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z
    World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
    Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
    Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The overexpression of scaffolding protein NEDD9 promotes migration and invasion in cervical cancer via tyrosine phosphorylated FAK and SRC.
    Sima N; Cheng X; Ye F; Ma D; Xie X; Lü W
    PLoS One; 2013; 8(9):e74594. PubMed ID: 24058594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma.
    Hu X; Xin Y; Xiao Y; Zhao J
    Pathol Oncol Res; 2014 Oct; 20(4):805-11. PubMed ID: 24643316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of NEDD9 and connexin-43 in neoplastic and stromal cells of gastric adenocarcinoma.
    Lerotić I; Vuković P; Hrabar D; Misir Z; Kruljac I; Pavić T; Forgač J; Ćaćić P; Ulamec M
    Bosn J Basic Med Sci; 2021 Oct; 21(5):542-548. PubMed ID: 33485292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer.
    Zhou L; Shang Y; Liu C; Li J; Hu H; Liang C; Han Y; Zhang W; Liang J; Wu K
    Int J Cancer; 2014 Nov; 135(10):2329-37. PubMed ID: 24706505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.
    Luo D; Huang H; Lu ML; Zhao GF; Chang J; Zheng MY; Wang Y
    Pathol Oncol Res; 2012 Apr; 18(2):491-7. PubMed ID: 22109561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of serum response factor is correlated with poor prognosis in patients with gastric cancer.
    Yin J; Lv X; Hu S; Zhao X; Liu Q; Xie H
    Hum Pathol; 2019 Mar; 85():10-17. PubMed ID: 30500416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance.
    Xue YZ; Sheng YY; Liu ZL; Wei ZQ; Cao HY; Wu YM; Lu YF; Yu LH; Li JP; Li ZS
    Tumour Biol; 2013 Apr; 34(2):895-9. PubMed ID: 23247867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysyl oxidase-like 4 (LOXL4) promotes proliferation and metastasis of gastric cancer via FAK/Src pathway.
    Li RK; Zhao WY; Fang F; Zhuang C; Zhang XX; Yang XM; Jiang SH; Kong FZ; Tu L; Zhang WM; Yang SL; Cao H; Zhang ZG
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):269-81. PubMed ID: 25216702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
    Guo J; Dong B; Ji JF; Wu AW
    World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAP2 is a Valuable Biomarker for Diagnosis and Prognostic in Patients with Gastric Cancer.
    Li L; Fu LQ; Wang HJ; Wang YY
    Pathol Oncol Res; 2020 Jan; 26(1):273-279. PubMed ID: 30047046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NEDD9 may regulate hepatocellular carcinoma cell metastasis by promoting epithelial-mesenchymal-transition and stemness via repressing Smad7.
    Wang Z; Shen M; Lu P; Li X; Zhu S; Yue S
    Oncotarget; 2017 Jan; 8(1):1714-1724. PubMed ID: 27974675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y; Zhang T; Wang Q
    Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer.
    Park JH; Lee BL; Yoon J; Kim J; Kim MA; Yang HK; Kim WH
    Hum Pathol; 2010 Dec; 41(12):1664-73. PubMed ID: 20869748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezrin is associated with gastric cancer progression and prognosis.
    Li L; Wang YY; Zhao ZS; Ma J
    Pathol Oncol Res; 2011 Dec; 17(4):909-15. PubMed ID: 21717114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.